Boundless Bio Inc (BOLD)

$1.41 +0.09 (6.82%)
Market Cap 29.55M
Revenue (ttm) 0.00
Net Income (ttm) -65.36M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 544,400
Avg Vol 117,824
Day's Range N/A - N/A
Shares Out 22.39M
Stochastic %K 80%
Beta -0.97
Analysts Sell
Price Target $3.50

Company Profile

Boundless Bio, Inc., a clinical-stage oncology company, develops cancer therapeutics to address the unmet need of patients with oncogene amplified tumors by interrogating extrachromosomal DNA (ecDNA). The company's lead product candidate is BBI-355, an ecDNA-directed therapeutic candidate and oral inhibitor of checkpoint kinase 1 that is in Phase 1/2 clinical trial in patients with oncogene amplified cancers. It also develops BBI-098, a picomolar biochemical inhibition of checkpoint kinase 1 dem...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 766 9912
Address:
10955 Alexandria Way, Suite 100, San Diego, United States
Golibajje
Golibajje Oct. 16 at 3:01 PM
$SPRB watch out $BOLD breakout started!!! - Trading 1/5th of cash!! - Oncogene amplifications, targeting most aggressive cancer, which has no cure!! - Multi billion $$$ market!! Catalyst: International Conference on Molecular Targets and Cancer Therapeutics taking place October 22-26, 2025 in Boston, MA https://investors.boundlessbio.com/static-files/fd938b87-a5eb-40a2-8e70-d9a62d90ed85
0 · Reply
Getthismoney101
Getthismoney101 Oct. 14 at 4:47 PM
$BOLD been holding this in my IRA since 1.05 , going to be a beauty $SPRB
0 · Reply
petemal
petemal Oct. 9 at 1:12 AM
$SPRB over valued raise coming in $BOLD looking good
1 · Reply
petemal
petemal Oct. 9 at 1:10 AM
$IVDA need some news $BOLD undervalued
0 · Reply
petemal
petemal Oct. 9 at 1:09 AM
$TDOC moving $BOLD next big mover
0 · Reply
petemal
petemal Oct. 9 at 1:08 AM
$RXRX seeing double digits $BOLD under valued
0 · Reply
stick_to_stocks
stick_to_stocks Oct. 4 at 9:57 AM
$BOLD there was an interesting slap a couple of days ago. Added
0 · Reply
Getthismoney101
Getthismoney101 Sep. 29 at 1:22 PM
$BOLD beaten down below cash value
0 · Reply
Getthismoney101
Getthismoney101 Sep. 29 at 1:06 PM
$BOLD LETS GO!!
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 9 at 12:24 PM
$BOLD Really good write-up that perfectly summarizes BOLD's present situation. So if you want to bring your BOLD knowledge up to date or just discover BOLD, this is required reading. https://beyondspx.com/quote/BOLD/analysis/unlocking-cancer-s-code-boundless-bio-s-ecdna-strategy-and-extended-runway-bold
0 · Reply
Latest News on BOLD
Boundless Bio Announces Upcoming Presentation at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Oct 13, 2025, 4:05 PM EDT - 3 days ago

Boundless Bio Announces Upcoming Presentation at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Boundless Bio Reports Second Quarter 2025 Financial Results and Business Highlights

Aug 5, 2025, 7:00 AM EDT - 2 months ago

Boundless Bio Reports Second Quarter 2025 Financial Results and Business Highlights

Boundless Bio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

Jun 5, 2025, 4:58 PM EDT - 4 months ago

Boundless Bio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

Boundless Bio Announces Portfolio Prioritization and Runway Extension

May 23, 2025, 4:01 PM EDT - 5 months ago

Boundless Bio Announces Portfolio Prioritization and Runway Extension

Boundless Bio Reports First Quarter 2025 Financial Results and Business Highlights

May 9, 2025, 7:00 AM EDT - 5 months ago

Boundless Bio Reports First Quarter 2025 Financial Results and Business Highlights

Boundless Bio to Participate in the Needham Virtual Healthcare Conference

Apr 3, 2025, 7:00 AM EDT - 7 months ago

Boundless Bio to Participate in the Needham Virtual Healthcare Conference

Boundless Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights

Mar 27, 2025, 7:00 AM EDT - 7 months ago

Boundless Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights

Boundless Bio to Participate in the Leerink Global Healthcare Conference

Feb 26, 2025, 7:00 AM EST - 8 months ago

Boundless Bio to Participate in the Leerink Global Healthcare Conference

Boundless Bio Appoints Robert Doebele, M.D., Ph.D., as Chief Medical Officer

Feb 3, 2025, 10:00 AM EST - 9 months ago

Boundless Bio Appoints Robert Doebele, M.D., Ph.D., as Chief Medical Officer

Boundless Bio Announces Pipeline and Leadership Updates

Dec 12, 2024, 4:01 PM EST - 11 months ago

Boundless Bio Announces Pipeline and Leadership Updates

Boundless Bio to Participate in the Piper Sandler Healthcare Conference

Nov 25, 2024, 7:00 AM EST - 11 months ago

Boundless Bio to Participate in the Piper Sandler Healthcare Conference

Boundless Bio Reports Third Quarter 2024 Financial Results and Business Highlights

Nov 7, 2024, 4:01 PM EST - 1 year ago

Boundless Bio Reports Third Quarter 2024 Financial Results and Business Highlights

Boundless Bio to Participate in the 2024 Guggenheim Global Healthcare Conference

Nov 5, 2024, 7:00 AM EST - 1 year ago

Boundless Bio to Participate in the 2024 Guggenheim Global Healthcare Conference

Boundless Bio to Participate in the 2024 Cantor Global Healthcare Conference

Sep 11, 2024, 7:00 AM EDT - 1 year ago

Boundless Bio to Participate in the 2024 Cantor Global Healthcare Conference

Boundless Bio Provides Business Updates Focused on Key Value Drivers and Reports Second Quarter 2024 Financial Results

Aug 12, 2024, 4:01 PM EDT - 1 year ago

Boundless Bio Provides Business Updates Focused on Key Value Drivers and Reports Second Quarter 2024 Financial Results

Boundless Bio to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

Jun 5, 2024, 7:00 AM EDT - 1 year ago

Boundless Bio to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

Boundless Bio Reports First Quarter 2024 Financial Results and Corporate Highlights

May 13, 2024, 7:00 AM EDT - 1 year ago

Boundless Bio Reports First Quarter 2024 Financial Results and Corporate Highlights

Boundless Bio to Present at the Citizens JMP Life Sciences Conference 2024

May 6, 2024, 8:00 AM EDT - 1 year ago

Boundless Bio to Present at the Citizens JMP Life Sciences Conference 2024

Boundless Bio Announces First Patient Dosed in First-in-Human Phase 1/2 Clinical Trial of BBI-825 in Cancer Patients with Resistance Gene Amplifications

Apr 11, 2024, 8:00 AM EDT - 1 year ago

Boundless Bio Announces First Patient Dosed in First-in-Human Phase 1/2 Clinical Trial of BBI-825 in Cancer Patients with Resistance Gene Amplifications

Boundless Bio Presents Preclinical and Clinical Pharmacodynamic Data on its Lead Extrachromosomal DNA (ecDNA)-Directed Therapy, BBI-355, at the American Association for Cancer Research Annual Meeting 2024

Apr 8, 2024, 8:00 AM EDT - 1 year ago

Boundless Bio Presents Preclinical and Clinical Pharmacodynamic Data on its Lead Extrachromosomal DNA (ecDNA)-Directed Therapy, BBI-355, at the American Association for Cancer Research Annual Meeting 2024

U.S. IPO Weekly Recap: Biotech Leads Short 3 IPO Week

Mar 30, 2024, 1:00 AM EDT - 1 year ago

U.S. IPO Weekly Recap: Biotech Leads Short 3 IPO Week

MMA MNDR NTCL NTHI ROTR UBXG WAY

Boundless Bio Announces Pricing of Initial Public Offering

Mar 27, 2024, 6:55 PM EDT - 1 year ago

Boundless Bio Announces Pricing of Initial Public Offering

U.S. IPO Weekly Recap: Tech IPOs Pop As End Of March Approaches

Mar 23, 2024, 12:20 AM EDT - 1 year ago

U.S. IPO Weekly Recap: Tech IPOs Pop As End Of March Approaches

ALAB AUNA INTJ MNDR RDDT

Boundless Bio Starts $100 Million U.S. IPO Plan

Mar 12, 2024, 4:16 PM EDT - 1 year ago

Boundless Bio Starts $100 Million U.S. IPO Plan

Golibajje
Golibajje Oct. 16 at 3:01 PM
$SPRB watch out $BOLD breakout started!!! - Trading 1/5th of cash!! - Oncogene amplifications, targeting most aggressive cancer, which has no cure!! - Multi billion $$$ market!! Catalyst: International Conference on Molecular Targets and Cancer Therapeutics taking place October 22-26, 2025 in Boston, MA https://investors.boundlessbio.com/static-files/fd938b87-a5eb-40a2-8e70-d9a62d90ed85
0 · Reply
Getthismoney101
Getthismoney101 Oct. 14 at 4:47 PM
$BOLD been holding this in my IRA since 1.05 , going to be a beauty $SPRB
0 · Reply
petemal
petemal Oct. 9 at 1:12 AM
$SPRB over valued raise coming in $BOLD looking good
1 · Reply
petemal
petemal Oct. 9 at 1:10 AM
$IVDA need some news $BOLD undervalued
0 · Reply
petemal
petemal Oct. 9 at 1:09 AM
$TDOC moving $BOLD next big mover
0 · Reply
petemal
petemal Oct. 9 at 1:08 AM
$RXRX seeing double digits $BOLD under valued
0 · Reply
stick_to_stocks
stick_to_stocks Oct. 4 at 9:57 AM
$BOLD there was an interesting slap a couple of days ago. Added
0 · Reply
Getthismoney101
Getthismoney101 Sep. 29 at 1:22 PM
$BOLD beaten down below cash value
0 · Reply
Getthismoney101
Getthismoney101 Sep. 29 at 1:06 PM
$BOLD LETS GO!!
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 9 at 12:24 PM
$BOLD Really good write-up that perfectly summarizes BOLD's present situation. So if you want to bring your BOLD knowledge up to date or just discover BOLD, this is required reading. https://beyondspx.com/quote/BOLD/analysis/unlocking-cancer-s-code-boundless-bio-s-ecdna-strategy-and-extended-runway-bold
0 · Reply
MorenitaScorp
MorenitaScorp Sep. 2 at 12:43 PM
$BOLD ⌚️
0 · Reply
topstockalerts
topstockalerts Sep. 2 at 11:03 AM
Pre Market Top Gainers PT2 $MLYS $FLGC $BOLD $TIXT $CYCU
0 · Reply
habesha_kingtchalla
habesha_kingtchalla Aug. 28 at 2:01 AM
$BOLD
0 · Reply
ZenithZephyr
ZenithZephyr Aug. 23 at 7:50 AM
$BOLD Boundless Bio Inc is a clinical stage oncology company with novel target approach
0 · Reply
JarvisFlow
JarvisFlow Aug. 11 at 11:00 AM
HC Wainwright & Co. has adjusted their stance on Boundless Bio ( $BOLD ), setting the rating to Buy with a target price of 5 → 4.
0 · Reply
TheOrangeBall
TheOrangeBall Jul. 29 at 11:08 PM
$BOLD how is this not pulling a $BHVN type run like they had a couple years ago??
0 · Reply
TheOrangeBall
TheOrangeBall Jul. 23 at 11:38 PM
$BOLD now begins the steady climb up
0 · Reply
Dirk1969
Dirk1969 Jul. 19 at 6:26 AM
$BOLD https://www.fiercebiotech.com/biotech/boundless-bio-lays-33-staff-lead-program-stumbles
1 · Reply
soopabox
soopabox Jul. 18 at 2:41 PM
$BOLD On the 3 month chart a very vague handle of a cup and handle seems to be forming. It looks more like a skillet instead of a cup. Not getting excited about it until -or- if it breaks 1.20 with volume.
1 · Reply
AceDeBase
AceDeBase Jul. 2 at 7:05 AM
$BOLD All tanks FULL. NOwhere to put ng
0 · Reply
AceDeBase
AceDeBase Jul. 2 at 6:56 AM
$BOLD SWITCH TO. TIMBER AS in. T i m b e r. Down
0 · Reply
TheOrangeBall
TheOrangeBall Jun. 29 at 12:26 AM
$BOLD way oversold now
0 · Reply